Iovance Biotherapeutics Ownership | Who Owns Iovance Biotherapeutics?
Iovance Biotherapeutics Ownership Summary
Iovance Biotherapeutics is owned by 60.88% institutional investors, 0.35% insiders, and 38.77% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 8.42% of IOVA shares. Vanguard Morn Total Stk Mkt Idx Investor is the top mutual fund, with 3.02% of its assets in Iovance Biotherapeutics shares.
IOVA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Iovance Biotherapeutics | 60.88% | 0.35% | 38.77% |
| Sector | Healthcare Stocks | 129.28% | 12.06% | -41.34% |
| Industry | Biotech Stocks | 181.42% | 11.67% | -93.09% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock funding, inc. /de | 37.90M | 8.42% | $561.74M |
| Mhr fund management | 28.97M | 8.11% | $101.67M |
| Blackrock | 21.23M | 7.97% | $170.23M |
| Vanguard group | 27.21M | 7.47% | $74.28M |
| State street | 21.70M | 4.82% | $321.52M |
| Vanguard capital management | 18.40M | 4.09% | $272.64M |
| Two sigma investments, lp | 13.69M | 3.83% | $48.04M |
| Vanguard portfolio management | 12.28M | 2.73% | $181.99M |
| Millennium management | 9.41M | 2.63% | $33.04M |
| Goldman sachs group | 8.76M | 2.45% | $30.75M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Knott david m jr | 1.17M | 9.44% | $17.27M |
| Orion investment | 2.08M | 8.19% | $30.88M |
| Mhr fund management | 28.97M | 7.43% | $101.67M |
| Rhenman & partners asset management ab | 2.50M | 4.11% | $37.09M |
| B group | 1.50M | 3.90% | $5.26M |
| Palo alto investors lp | 6.35M | 3.41% | $22.29M |
| Xcelsior advisor partners | 1.84M | 1.83% | $27.29M |
| Kennondale capital management | 188.24K | 1.81% | $2.79M |
| Invenomic capital management lp | 8.50M | 1.37% | $29.82M |
| Virtus investment advisers | 413.11K | 1.35% | $6.12M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Two sigma investments, lp | 13.69M | 0.04% | 9.29M |
| D. e. shaw | 8.02M | 0.02% | 4.19M |
| Vanguard group | 27.21M | 0.00% | 3.15M |
| Millennium management | 9.41M | 0.01% | 2.83M |
| Price t rowe associates inc /md/ | 3.17M | 0.00% | 1.98M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Hood river capital management | - | - | -9.22M |
| Long focus capital management | 2.10M | 0.19% | -6.50M |
| Macquarie group | - | - | -4.79M |
| Artisan partners limited partnership | - | - | -4.41M |
| Avoro capital advisors | - | - | -3.50M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Arrowstreet capital, limited partnership | 1.12M | 0.01% | 1.12M | $16.56M |
| Voloridge investment management | 1.02M | 0.01% | 1.02M | $3.59M |
| Artal group | 1.01M | 0.21% | 1.01M | $8.11M |
| First trust advisors lp | 649.13K | 0.01% | 649.13K | $9.62M |
| Norges bank | 416.24K | 0.00% | 416.24K | $3.08M |
Sold Out
| Holder | Change |
|---|---|
| Nbc securities | -4.00 |
| Global financial private client | -4.00 |
| Smallwood wealth investment management | -9.00 |
| Pier 88 investment partners | -10.00 |
| Capital performance advisors llp | -11.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | 319 | 4.59% | 274,052,979 | -5.43% | 60 | 1.47% | 180 | 2.86% | 84 | 27.27% |
| Jun 30, 2026 | 304 | 0.66% | 291,042,355 | 8.15% | 64 | 1.56% | 179 | -4.79% | 62 | 6.90% |
| Mar 31, 2026 | 150 | -45.05% | 64,023,711 | -75.53% | 17 | 0.35% | 88 | -41.72% | 29 | -54.69% |
| Dec 31, 2025 | 168 | -35.63% | 143,064,086 | -32.81% | 39 | 0.97% | 89 | -29.37% | 43 | -41.89% |
| Sep 30, 2025 | 247 | 0.82% | 212,726,606 | 4.22% | 63 | 1.71% | 118 | -4.07% | 69 | -1.43% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Morn Total Stk Mkt Idx Investor | 13.49M | 3.02% | 1.01M |
| Vanguard Total Stock Mkt Idx Inv | 13.49M | 3.02% | 1.01M |
| Vanguard MStar Total Stk Mkt Idx Invest | 13.55M | 2.99% | 38.52K |
| Vanguard US Total Market Shares ETF | 8.71M | 2.66% | 762.45K |
| State Street® SPDR® S&P® Biotech ETF | 12.07M | 2.61% | 314.70K |
| iShares Russell 2000 ETF | 10.08M | 2.18% | - |
| Hood River Small-Cap Growth Instl | 5.10M | 1.53% | - |
| Macquarie Small Cap Core I | 4.08M | 1.22% | 56.67K |
| Vanguard Small Cap Index | 4.85M | 1.07% | -32.16K |
| SPDR® S&P Biotech ETF | 3.56M | 0.98% | 7.96K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jun 05, 2025 | Kirby Daniel Gordon | Chief Commercial Officer | Buy | $55.20K |
| May 23, 2025 | Puri Raj K. | Chief Regulatory Officer | Buy | $9.74K |
| May 14, 2025 | Vogt Frederick G | Interim CEO & General Counsel | Buy | $42.25K |
| Nov 12, 2024 | Maynard Ryan D | - | Sell | $503.00K |
| Feb 20, 2024 | MCPEAK MERRILL A | - | Buy | $2.29M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q4 | - | - |
| 2026 Q3 | - | - |
| 2026 Q2 | - | - |
| 2026 Q1 | - | - |
| 2025 Q4 | - | - |
IOVA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools